These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations. Ferrari F; Cerlesi MC; Malfacini D; Asth L; Gavioli EC; Journigan BV; Kamakolanu UG; Meyer ME; Yasuda D; Polgar WE; Rizzi A; Guerrini R; Ruzza C; Zaveri NT; Calo G Eur J Pharmacol; 2016 Dec; 793():1-13. PubMed ID: 27780725 [TBL] [Abstract][Full Text] [Related]
8. A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ. Guerrini R; Marzola E; Trapella C; Pela' M; Molinari S; Cerlesi MC; Malfacini D; Rizzi A; Salvadori S; Calo' G Bioorg Med Chem; 2014 Jul; 22(14):3703-12. PubMed ID: 24878361 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol. Gündüz O; Rizzi A; Baldisserotto A; Guerrini R; Spagnolo B; Gavioli EC; Kocsis L; Magyar A; Benyhe S; Borsodi A; Calò G Eur J Pharmacol; 2006 Jun; 539(1-2):39-48. PubMed ID: 16682024 [TBL] [Abstract][Full Text] [Related]
10. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor. Peng YL; Chang M; Dong SL; Li W; Han RW; Fu GX; Chen Q; Wang R Regul Pept; 2006 May; 134(2-3):75-81. PubMed ID: 16516988 [TBL] [Abstract][Full Text] [Related]
11. Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo). Bird MF; Cerlesi MC; Brown M; Malfacini D; Vezzi V; Molinari P; Micheli L; Di Cesare Mannelli L; Ghelardini C; Guerrini R; Calò G; Lambert DG PLoS One; 2016; 11(6):e0156897. PubMed ID: 27272042 [TBL] [Abstract][Full Text] [Related]
12. Structure activity studies of nociceptin/orphanin FQ(1-13)-NH2 derivatives modified in position 5. Guerrini R; Marzola E; Trapella C; Pacifico S; Cerlesi MC; Malfacini D; Ferrari F; Bird MF; Lambert DG; Salvadori S; Calo G Bioorg Med Chem; 2015 Apr; 23(7):1515-20. PubMed ID: 25716007 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. Fischetti C; Camarda V; Rizzi A; Pelà M; Trapella C; Guerrini R; McDonald J; Lambert DG; Salvadori S; Regoli D; Calo' G Eur J Pharmacol; 2009 Jul; 614(1-3):50-7. PubMed ID: 19445927 [TBL] [Abstract][Full Text] [Related]
14. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors. Ibba M; Kitayama M; McDonald J; Calo G; Guerrini R; Farkas J; Toth G; Lambert DG Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):553-61. PubMed ID: 18807245 [TBL] [Abstract][Full Text] [Related]
15. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor. Rizzi A; Spagnolo B; Wainford RD; Fischetti C; Guerrini R; Marzola G; Baldisserotto A; Salvadori S; Regoli D; Kapusta DR; Calo G Peptides; 2007 Jun; 28(6):1240-51. PubMed ID: 17532097 [TBL] [Abstract][Full Text] [Related]
18. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells. Wright KE; McDonald J; Barnes TA; Rowbotham DJ; Guerrini R; Calo' G; Lambert DG Neurosci Lett; 2003 Aug; 346(3):145-8. PubMed ID: 12853105 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2. Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020 [TBL] [Abstract][Full Text] [Related]
20. Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands. Asth L; Ruzza C; Malfacini D; Medeiros I; Guerrini R; Zaveri NT; Gavioli EC; Calo' G Neuropharmacology; 2016 Jun; 105():434-442. PubMed ID: 26867504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]